Tableau de bordPortefeuillesListe de surveillanceCommunautéDécouvrirFiltre
NOT FOR DISTRIBUTION

Melexis NV

ENXTBR:MELE Rapport sur les actions

Capitalisation boursière : €2.7b

  • Présentation de l'entreprise
    • Évaluation
    • Croissance future
    • Performances passées
    • Santé financière
    • Dividende
  • Gestion
  • Propriété
  • Autres informations
  • Communauté boursière

Melexis Croissance future

Future contrôle des critères 4/6

Melexis devrait augmenter ses bénéfices et son chiffre d'affaires de 19.2% et de 8.7% par an respectivement. Le BPA devrait croître de de 19.2% par an. Le rendement des capitaux propres devrait être 40.1% dans 3 ans.

Informations clés

19.2%

Taux de croissance des bénéfices

19.18%

Taux de croissance du BPA

Semiconductor croissance des bénéfices24.9%
Taux de croissance des recettes8.7%
Rendement futur des capitaux propres40.09%
Couverture par les analystes

Good

Dernière mise à jour18 Aug 2026

Mises à jour récentes de la croissance future

Article d’analyse • Feb 08

Melexis NV (EBR:MELE) Yearly Results: Here's What Analysts Are Forecasting For This Year

It's been a sad week for Melexis NV ( EBR:MELE ), who've watched their investment drop 16% to €53.25 in the week since...
Article d’analyse • Aug 02

Melexis NV Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

A week ago, Melexis NV ( EBR:MELE ) came out with a strong set of half-yearly numbers that could potentially lead to a...

Recent updates

User avatar
Mise à jour du récit • Aug 09

MELE: Future Returns Will Rely On Higher P/E Despite Softer Outlook

Analysts have raised their fair value estimate for Melexis from €52 to €56 as part of a broader recalibration of price targets, citing updated assumptions on discount rates, growth expectations and valuation multiples following recent sector commentary. What's in the News for Melexis No recent Melexis specific news items were available from the provided sources as of 6 Aug 2026.
Article d’analyse • Aug 05

Investors Can Find Comfort In Melexis' (EBR:MELE) Earnings Quality

Shareholders appeared unconcerned with Melexis NV's ( EBR:MELE ) lackluster earnings report last week. We did some...
User avatar
Mise à jour du récit • Jul 26

MELE: Higher 75 Price Level Will Test Earnings And Margin Conviction

The latest Narrative Update on Melexis reflects a higher analyst price target of €75, up from €71.92, as analysts factor in a slightly richer assumed future P/E and profit margin, along with Street research that has lifted formal targets while becoming more neutral on the stock overall. Analyst Commentary Recent Street research on Melexis paints a mixed picture, with a higher cluster of price targets around €75 but a more cautious stance on rating, as some analysts balance potential growth in semiconductor demand against concerns tied to broader tech hardware and AI sentiment.
User avatar
Mise à jour du récit • Jul 12

MELE: Street Repricing And 2026 Outlook Will Support Further Upside Potential

The analyst fair value estimate for Melexis has been raised from €92 to €96, reflecting updated assumptions on growth, margins and discount rates, along with recent Street research where multiple firms lifted their price targets even as one shifted its rating to Hold. Analyst Commentary Recent Street research on Melexis presents a mixed backdrop, with some caution around the broader tech hardware sector alongside higher fair value and price targets.
Article d’analyse • Feb 08

Melexis NV (EBR:MELE) Yearly Results: Here's What Analysts Are Forecasting For This Year

It's been a sad week for Melexis NV ( EBR:MELE ), who've watched their investment drop 16% to €53.25 in the week since...
Article d’analyse • Feb 07

Melexis (EBR:MELE) Has Affirmed Its Dividend Of €1.68

Melexis NV ( EBR:MELE ) has announced that it will pay a dividend of €1.68 per share on the 21st of May. This makes the...
Article d’analyse • Jan 03

Melexis NV's (EBR:MELE) P/E Still Appears To Be Reasonable

With a price-to-earnings (or "P/E") ratio of 21.7x Melexis NV ( EBR:MELE ) may be sending bearish signals at the...
Article d’analyse • Nov 28

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Article d’analyse • Nov 15

Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Key Insights The projected fair value for Melexis is €54.64 based on 2 Stage Free Cash Flow to Equity With €55.65 share...
Article d’analyse • Oct 23

Returns On Capital At Melexis (EBR:MELE) Have Stalled

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
Article d’analyse • Oct 09

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Melexis NV's ( EBR:MELE ) investors are due to receive a payment of €0.91 per share on 16th of October. This means the...
Article d’analyse • Sep 11

At €66.95, Is It Time To Put Melexis NV (EBR:MELE) On Your Watch List?

While Melexis NV ( EBR:MELE ) might not have the largest market cap around , it saw a decent share price growth of 14...
Article d’analyse • Aug 02

Melexis NV Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

A week ago, Melexis NV ( EBR:MELE ) came out with a strong set of half-yearly numbers that could potentially lead to a...
Article d’analyse • Jul 09

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Article d’analyse • Jun 26

Is Melexis (EBR:MELE) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Article d’analyse • May 13

Earnings Not Telling The Story For Melexis NV (EBR:MELE) After Shares Rise 32%

Melexis NV ( EBR:MELE ) shareholders would be excited to see that the share price has had a great month, posting a 32...
Article d’analyse • May 07

Shareholders May Be Wary Of Increasing Melexis NV's (EBR:MELE) CEO Compensation Package

Key Insights Melexis to hold its Annual General Meeting on 13th of May Total pay for CEO Marc Biron includes €385.0k...
Article d’analyse • May 04

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €1.68

The board of Melexis NV ( EBR:MELE ) has announced that it will pay a dividend of €1.68 per share on the 22nd of May...
Article d’analyse • Apr 06

Under The Bonnet, Melexis' (EBR:MELE) Returns Look Impressive

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Article d’analyse • Mar 23

Melexis NV's (EBR:MELE) Shares May Have Run Too Fast Too Soon

There wouldn't be many who think Melexis NV's ( EBR:MELE ) price-to-earnings (or "P/E") ratio of 13.2x is worth a...
Article d’analyse • Mar 09

At €58.75, Is It Time To Put Melexis NV (EBR:MELE) On Your Watch List?

Melexis NV ( EBR:MELE ), is not the largest company out there, but it saw significant share price movement during...
Article d’analyse • Feb 08

Melexis NV Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Shareholders might have noticed that Melexis NV ( EBR:MELE ) filed its annual result this time last week. The early...
Article d’analyse • Feb 04

Is Melexis (EBR:MELE) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Article d’analyse • Jan 08

Is Melexis NV (EBR:MELE) Trading At A 44% Discount?

Key Insights Melexis' estimated fair value is €104 based on 2 Stage Free Cash Flow to Equity Current share price of...
Article d’analyse • Dec 26

Melexis (EBR:MELE) Knows How To Allocate Capital Effectively

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Article d’analyse • Nov 29

Improved Earnings Required Before Melexis NV (EBR:MELE) Shares Find Their Feet

With a price-to-earnings (or "P/E") ratio of 11.3x Melexis NV ( EBR:MELE ) may be sending bullish signals at the...
Article d’analyse • Oct 31

These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Article d’analyse • Oct 11

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

The board of Melexis NV ( EBR:MELE ) has announced that it will pay a dividend of €0.91 per share on the 17th of...
Article d’analyse • Oct 01

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Melexis NV ( EBR:MELE ), might not be a large cap stock, but it received a lot of attention from a substantial price...
Article d’analyse • Aug 31

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Melexis NV's ( EBR:MELE ) healthy profit numbers didn't contain any surprises for investors. We think this is due to...
Article d’analyse • Aug 19

There's Reason For Concern Over Melexis NV's (EBR:MELE) Price

With a median price-to-earnings (or "P/E") ratio of close to 16x in Belgium, you could be forgiven for feeling...
Article d’analyse • Aug 02

Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

Melexis NV ( EBR:MELE ) last week reported its latest quarterly results, which makes it a good time for investors to...
Article d’analyse • Jul 04

A Look At The Fair Value Of Melexis NV (EBR:MELE)

Key Insights Melexis' estimated fair value is €83.32 based on 2 Stage Free Cash Flow to Equity With €82.70 share price...
Article d’analyse • Jun 20

Is There Now An Opportunity In Melexis NV (EBR:MELE)?

Melexis NV ( EBR:MELE ), is not the largest company out there, but it saw a decent share price growth of 19% on the...
Article d’analyse • Jun 07

Melexis (EBR:MELE) Knows How To Allocate Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Article d’analyse • May 22

Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Article d’analyse • May 08

Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

Key Insights Melexis' Annual General Meeting to take place on 14th of May Total pay for CEO Marc Biron includes €381.7k...
Article d’analyse • Mar 27

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Key Insights Melexis' estimated fair value is €81.96 based on 2 Stage Free Cash Flow to Equity With €75.45 share price...
Article d’analyse • Mar 14

At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Melexis NV ( EBR:MELE ), is not the largest company out there, but it received a lot of attention from a substantial...
Article d’analyse • Feb 28

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
Article d’analyse • Feb 15

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

The recent earnings posted by Melexis NV ( EBR:MELE ) were solid, but the stock didn't move as much as we expected. We...
Article d’analyse • Jan 02

Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Article d’analyse • Dec 09

What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Melexis NV ( EBR:MELE ), is not the largest company out there, but it led the ENXTBR gainers with a relatively large...
Article d’analyse • Nov 27

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Article d’analyse • Nov 15

Melexis (EBR:MELE) Knows How To Allocate Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Prévisions de croissance des bénéfices et des revenus

ENXTBR:MELE - Estimations futures des analystes et données financières antérieures (EUR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20281,04219120228812
12/31/202795315816225413
12/31/202686912221426812
6/30/2026849104204239N/A
3/31/2026843111166199N/A
12/31/202584011397126N/A
9/30/202582310893126N/A
6/30/202585513290129N/A
3/31/2025889143127169N/A
12/31/2024933171120173N/A
9/30/2024986203101169N/A
6/30/202498720967150N/A
3/31/2024978211-913N/A
12/31/2023964209-923N/A
9/30/2023938212-747N/A
6/30/2023909204-2142N/A
3/31/2023881199132184N/A
12/31/2022836197148188N/A
9/30/2022779178158194N/A
6/30/2022722166124161N/A
3/31/2022672152105140N/A
12/31/2021644131103142N/A
9/30/202162512295132N/A
6/30/202158410092123N/A
3/31/20215257680109N/A
12/31/2020508697196N/A
9/30/2020487617295N/A
6/30/20204896181104N/A
3/31/202050967N/A101N/A
12/31/201948760N/A94N/A
9/30/201950173N/A105N/A
6/30/201952588N/A96N/A
3/31/2019547101N/A98N/A
12/31/2018569115N/A100N/A
9/30/2018560114N/A78N/A
6/30/2018541112N/A89N/A
3/31/2018527114N/A106N/A
12/31/2017512111N/A113N/A
9/30/2017499109N/A116N/A
6/30/2017486107N/A96N/A
3/31/201747099N/A108N/A
12/31/201645696N/A108N/A
9/30/201643993N/A116N/A
6/30/201642693N/A134N/A
3/31/201641595N/A127N/A
12/31/201540099N/A115N/A
9/30/201538697N/A109N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de MELE ( 19.2% par an) est supérieure au taux d'épargne ( 2.6% ).

Bénéfices vs marché: Les bénéfices de MELE ( 19.2% par an) devraient croître plus rapidement que le marché Belgian ( 11.6% par an).

Croissance élevée des bénéfices: Les bénéfices de MELE devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de MELE ( 8.7% par an) devrait croître plus rapidement que le marché Belgian ( 7.5% par an).

Croissance élevée des revenus: Le chiffre d'affaires de MELE ( 8.7% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de MELE devrait être très élevé dans 3 ans ( 40.1 %).


Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/09/21 15:19
Cours de l'action en fin de journée2026/09/21 00:00
Les revenus2026/06/30
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
  • Formulaire 10-K de la SEC
  • Formulaire 10-Q de la SEC
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
  • Rapports de recherche des analystes
  • Blue Matrix
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
  • Données de marché ICE
  • Formulaire S-1 de la SEC
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
  • Formulaire 4 de la SEC
  • Formulaire 13D de la SEC
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
  • Formulaire 10-K de la SEC
  • Formulaire SEC DEF 14A
Principaux développements10 ans
  • Annonces de l'entreprise
  • Formulaire 8-K de la SEC

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Melexis NV est couverte par 19 analystes. 13 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Tammy QiuBerenberg
Trion ReidBerenberg
Anna PatriceBerenberg

Prenez de meilleures décisions d’investissement partout

Scannez pour télécharger
Ouvrir l’App StoreOuvrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Voir les sources de données
Marchés
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Idées d'investissement
  • Sociétés sous-évaluées
  • Les géants du dividende
  • Achats d'initiés
  • Énergie nucléaire
  • Véhicules autonomes
  • Intelligence artificielle
  • Cryptomonnaie et blockchain
  • cybersécurité
  • Plus d'idées
Communautés boursières
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Outils et fonctionnalités
  • Suivi de portefeuille
  • Filtre et alertes sur les actions
  • Narratives et valeurs équitables
  • Calculateur de dividendes
Actualités et découvertes
  • Dernières actualités de stock
  • Aperçus du marché mondial
  • Le Foxhole
  • Idées d'investissement
  • Narratives de la communauté
  • Quoi de neuf
Simply Wall St
  • Plans et tarifs
  • Publicité
  • À propos de nous
  • Nous contacter
  • Carrières
  • Centre d'aide
  • Apprendre à investir en bourse
  • Programme d'affiliation
  • Affaires et entreprises
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Conditions générales d'utilisation
  • Politique de confidentialité
  • Conditions relatives à l'IA
  • Guide des services financiers